Information

Related Research Units

Education

Undergraduate School

College of the Holy Cross
1990 Worcester MA

Medical School

Washington University
1995 St. Louis MO

Internship

Pediatrics St. Louis Children's Hospital
1996 St. Louis MO

Residency

Pediatrics St. Louis Children's Hospital
1998 St. Louis MO

Fellowship

Pediatric Nephrology Boston Children's Hospital
2002 Boston MA United States

Media

Caregiver Profile

Meet Dr. Nancy Rodig

Publications

  1. Evaluation for genetic disease in kidney transplant candidates: A practice resource. Am J Transplant. 2025 Feb; 25(2):237-249. View Abstract
  2. Pediatric Kidney Transplantation: Cancer and Cancer Risk. Semin Nephrol. 2024 Jan; 44(1):151501. View Abstract
  3. Correction to: Outcomes based on induction regimens in pediatric kidney transplantation: a NAPRTCS and PHIS collaborative study. Pediatr Nephrol. 2023 Oct; 38(10):3503. View Abstract
  4. Programmed cell death ligand 1 expression associated with subtypes of post-transplant lymphoproliferative disorder among pediatric kidney transplant recipients. Clin Transplant. 2023 12; 37(12):e15134. View Abstract
  5. Exome sequencing identifies a likely causative variant in 53% of families with ciliopathy-related features on renal ultrasound after excluding NPHP1 deletions. Genes Dis. 2024 Sep; 11(5):101111. View Abstract
  6. Characterization of the prenatal renal phenotype associated with 17q12, HNF1B, microdeletions. Prenat Diagn. 2024 02; 44(2):237-246. View Abstract
  7. Fecal Microbiota Transplant in Pediatric Solid Organ Transplant Recipients. Transplantation. 2023 09 01; 107(9):2073-2077. View Abstract
  8. Outcomes based on induction regimens in pediatric kidney transplantation: a NAPRTCS and PHIS collaborative study. Pediatr Nephrol. 2023 10; 38(10):3455-3464. View Abstract
  9. Genetic evaluation of living kidney donor candidates: A review and recommendations for best practices. Am J Transplant. 2023 05; 23(5):597-607. View Abstract
  10. OXGR1 is a candidate disease gene for human calcium oxalate nephrolithiasis. Genet Med. 2023 03; 25(3):100351. View Abstract
  11. Associations of body mass index (BMI) and BMI change with progression of chronic kidney disease in children. Pediatr Nephrol. 2023 04; 38(4):1257-1266. View Abstract
  12. COVID-19 in pediatric kidney transplantation: a follow-up report of the Improving Renal Outcomes Collaborative. Pediatr Nephrol. 2023 02; 38(2):537-547. View Abstract
  13. Presentation and outcomes of post-transplant lymphoproliferative disorder at a single institution pediatric transplant center. Pediatr Transplant. 2022 08; 26(5):e14268. View Abstract
  14. The development of end stage renal disease in two patients with PMM2-CDG. JIMD Rep. 2022 Mar; 63(2):131-136. View Abstract
  15. Reverse phenotyping facilitates disease allele calling in exome sequencing of patients with CAKUT. Genet Med. 2022 02; 24(2):307-318. View Abstract
  16. Implementing a regional standardized BK polyomavirus screening protocol across eleven transplant centres. Transpl Int. 2021 12; 34(12):2680-2685. View Abstract
  17. COVID-19 in pediatric kidney transplantation: The Improving Renal Outcomes Collaborative. Am J Transplant. 2021 08; 21(8):2740-2748. View Abstract
  18. Longitudinal outcomes of body mass index in overweight and obese children with chronic kidney disease. Pediatr Nephrol. 2021 07; 36(7):1851-1860. View Abstract
  19. Incidence and risk factors of kidney allograft loss due to BK nephropathy in the pediatric population: A retrospective analysis of the UNOS/OPTN database. Pediatr Transplant. 2021 Aug; 25(5):e13927. View Abstract
  20. Expecting the unexpected: COVID-19 in Kidney Transplant Recipients within United Network for Organ Sharing Region 1. Transpl Int. 2020 12; 33(12):1843-1844. View Abstract
  21. Mutations of the Transcriptional Corepressor ZMYM2 Cause Syndromic Urinary Tract Malformations. Am J Hum Genet. 2020 10 01; 107(4):727-742. View Abstract
  22. Early outcomes comparing induction with antithymocyte globulin vs alemtuzumab in two steroid-avoidance protocols in pediatric renal transplantation. Pediatr Transplant. 2020 05; 24(3):e13685. View Abstract
  23. Perioperative renal transplantation management in small children using adult-sized living or deceased donor kidneys: A single-center experience. Pediatr Transplant. 2019 11; 23(7):e13553. View Abstract
  24. Whole-Exome Sequencing Enables a Precision Medicine Approach for Kidney Transplant Recipients. J Am Soc Nephrol. 2019 02; 30(2):201-215. View Abstract
  25. New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines. Transpl Infect Dis. 2018 Dec; 20(6):e12985. View Abstract
  26. Whole-Exome Sequencing Identifies Causative Mutations in Families with Congenital Anomalies of the Kidney and Urinary Tract. J Am Soc Nephrol. 2018 09; 29(9):2348-2361. View Abstract
  27. Whole Exome Sequencing Reveals a Monogenic Cause of Disease in ˜43% of 35 Families With Midaortic Syndrome. Hypertension. 2018 04; 71(4):691-699. View Abstract
  28. Bilateral native nephrectomy to reduce oxalate stores in children at the time of combined liver-kidney transplantation for primary hyperoxaluria type 1. Pediatr Nephrol. 2018 05; 33(5):881-887. View Abstract
  29. Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome. Clin J Am Soc Nephrol. 2018 01 06; 13(1):53-62. View Abstract
  30. Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int. 2018 01; 93(1):204-213. View Abstract
  31. Analysis of 24 genes reveals a monogenic cause in 11.1% of cases with steroid-resistant nephrotic syndrome at a single center. Pediatr Nephrol. 2018 02; 33(2):305-314. View Abstract
  32. A Regional Evaluation of Survival of Infants with End-Stage Renal Disease. Neonatology. 2017; 112(1):73-79. View Abstract
  33. Urinary NGAL deficiency in recurrent urinary tract infections. Pediatr Nephrol. 2017 06; 32(6):1077-1080. View Abstract
  34. Renal involvement in the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) disorder. Pediatr Nephrol. 2015 Jul; 30(7):1197-202. View Abstract
  35. Treatment and outcomes of immune cytopenias following solid organ transplant in children. Pediatr Blood Cancer. 2015 02; 62(2):214-218. View Abstract
  36. Methylmalonic acidemia: a megamitochondrial disorder affecting the kidney. Pediatr Nephrol. 2014 Nov; 29(11):2139-46. View Abstract
  37. Growth in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children Study. Pediatr Nephrol. 2014 Oct; 29(10):1987-95. View Abstract
  38. Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum Mutat. 2012 Mar; 33(3):457-66. View Abstract
  39. Rapid reversal of uremic neuropathy following renal transplantation in an adolescent. Pediatr Transplant. 2012 Nov; 16(7):E296-300. View Abstract
  40. Risk factors for urinary tract infection after renal transplantation and its impact on graft function in children and young adults. J Urol. 2010 Oct; 184(4):1462-7. View Abstract
  41. Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients. Pediatr Transplant. 2006 Jun; 10(4):505-12. View Abstract
  42. Acute arsenic poisoning in two siblings. Pediatrics. 2005 Jul; 116(1):249-57. View Abstract
  43. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol. 2003 Nov; 33(11):3117-26. View Abstract

Contact Nancy Rodig